Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBPP) Long-Term Investments (2024 - 2025)

Historic Long-Term Investments for Regen BioPharma (RGBPP) over the last 2 years, with Q2 2025 value amounting to $17733.0.

  • Regen BioPharma's Long-Term Investments changed N/A to $17733.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $17733.0, marking a year-over-year change of. This contributed to the annual value of $17733.0 for FY2024, which is N/A changed from last year.
  • Per Regen BioPharma's latest filing, its Long-Term Investments stood at $17733.0 for Q2 2025.
  • Regen BioPharma's Long-Term Investments' 5-year high stood at $17733.0 during Q3 2024, with a 5-year trough of $17733.0 in Q3 2024.